Naltrexone vs. Topiramate: FDA-Approved vs. Off-Label Options for MAUD
Psychopharmacology and Psychiatry Updates
00:00
Comparing Naltrexone and Topiramate in Alcohol Use Disorder Treatment
This chapter analyzes the effectiveness of naltrexone and topiramate in treating alcohol use disorder (AUD). It reviews FDA-approved medications, prevalence of AUD, and presents clinical trial findings, suggesting that both medications are similarly effective, with topiramate showing promise as a first-line treatment option.
Transcript
Play full episode
